Showing search results for "Dyrskjøt L"
, Muscle, Patients, Patient, Risk, Gene, Treatment, Tumor, DNA, Tumors, Recurrence, Proteins, Tissue,
, Biomarkers, Urine,
Information and abstracts for author publications
High expression of karyopherin-α2 defines poor prognosis in non-muscle-invasive bladder cancer and in patients with invasive bladder cancer undergoing radical cystectomy.
Clinical cancer research : an official journal of the American Association for Cancer Research
Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy.
International journal of cancer. Journal international du cancer
Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer development.
British journal of cancer
Low ANXA10 expression is associated with disease aggressiveness in bladder cancer.
The American journal of pathology
Multicenter validation of cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle-invasive bladder cancer.
The American journal of pathology
Cathepsin E, maspin, Plk1, and survivin are promising prognostic protein markers for progression in non-muscle invasive bladder cancer.
The functional role of the novel biomarker karyopherin α 2 (KPNA2) in cancer.
Diagnosis of bladder cancer recurrence based on urinary levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 hypermethylation.
BMC medical genomics
miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer.
High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression.
Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts.
Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer.
Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer.
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
A Syngeneic Mouse B-Cell Lymph…
Use of Principal Components for Scaling Up Topographic Models to Map Soil Redistribution and Soil Organic Carbon
Use of Principal Components fo…
Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
Amplification of Near Full-len…
Assays for Studying the Role of Vitronectin in Bacterial Adhesion and Serum Resistance
Assays for Studying the Role o…
Analyzing Protein Architectures and Protein-Ligand Complexes by Integrative Structural Mass Spectrometry
Analyzing Protein Architecture…
Small-Scale Colorimetric Assays of Intracellular Lactate and Pyruvate in the Nematode
Small-Scale Colorimetric Assay…
Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
Efficient Purification and LC-…
Determination of Reproductive Competence by Confirming Pubertal Onset and Performing a Fertility Assay in Mice and Rats
Determination of Reproductive …
Fabricating a Kidney Cortex Extracellular Matrix-Derived Hydrogel
Fabricating a Kidney Cortex Ex…
Stress-Enhanced Fear Learning, a Robust Rodent Model of Post-Traumatic Stress Disorder
Stress-Enhanced Fear Learning,…
JoVE subscription required to view articles
Related JoVE Videos